Pharmacy Healthcare Solutions Inc. (PHSI) consults with pharmaceutical manufacturers, PBMs, retail pharmacy chains, and software companies on strategic business and marketing issues. Consulting projects across these market segments provide PHSI with the latest information on emerging trends as well as new products and services. Our consultants have extensive retail, mail service and managed care experience to create actionable recommendations for our clients’ challenging business issues.
PHSI Vice President Don Dietz, Director of Business Development Fred Hamlin, and PHSI Consultants Melissa Krause and Ashley Ellek will be attending AMCP Nexus 2016 in National Harbor, MD on October 3rd-6th. To schedule a meeting with PHSI during the conference, click here to contact us.
FOR IMMEDIATE RELEASE PHSI Celebrates 20 Year Anniversary Pharmacist-led consulting firm reaches milestone during NACDS TSE Pittsburgh, PA, August 4, 2016 – Pharmacy Healthcare Solutions, Inc. (PHSI), a pharmacist-led business consulting firm, will celebrate their 20th anniversary on August 7th, during the NACDS TSE Conference in Boston. Founded in 1996 by President Tim Kosty and Read More →
The recent push to focus on value-based healthcare through accountable care organizations (ACOs) is changing incentives for physician practices and health care systems. Incentivized care is also now moving into the pharmacy world. With more focus than ever on managing outcomes, improving adherence, and preventing adverse reactions, pharmacies are becoming contractually responsible for whether or Read More →
The following linked article provides viewpoints from many different stakeholders regarding drug pricing. One of the good discussion points includes that if a manufacturer brings a product to market, Medicaid will pay for it. Americans drive innovation but just because something is available, does that mean the expectation is that it is covered by health Read More →
Vermont became the first state to enforce drug pricing transparency from pharmaceutical companies. The bill took effect on June 2nd and requires manufacturers to be open about what goes into the pricing of their drug. The intent is for manufacturers to be held more accountable for their pricing. An act related to prescription drugs (Act Read More →
The next National Prescription Drug Take-Back Day sponsored by the Drug Enforcement Administration (DEA) is scheduled for Saturday, October 22, 2016 from 10:00 am to 2:00 pm at participating locations. Additional information on disposal sites will be made available by September 22, 2016. Visit the DEA website at http://www.deadiversion.usdoj.gov/drug_disposal/index.html for more information on drug disposal. Read More →